CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Jung Hwan Yu, Jin-Woo Lee
Clin Mol Hepatol. 2019;25(3):280-282.   Published online 2019 January 21    DOI: https://doi.org/10.3350/cmh.2018.0104

Excel Download

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Clinical and Molecular Hepatology. 2019;25(3):280-282   Crossref logo
Link1 Link2 Link3

P1218 STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 3 DOESN'T AFFECT THE OUTCOME OF PEGINTERFERON ALPHA-2a PLUS RIBAVIRIN TREATMENT
Journal of Hepatology. 2014;60(1):S494   Crossref logo
Link1 Link2

P1-124: Does hepatic involvement affect outcome in dengue Infection?
Journal of Viral Hepatitis. 2018;25:89-90   Crossref logo
Link1 Link2

Adipokines, insulin resistance, hepatic steatosis, and necroinflammation in patients with chronic viral hepatitis
Asian Biomedicine. 2014;8(4):557-564   Crossref logo
Link1 Link2

1120 ALTERED SERUM ADIPOCYTOKINES LEVELS DO AFFECT HEPATIC STEATOSIS AND FIBROSIS IN CHRONIC HEPATITIS B AND CHRONIC HEPATITIS C INDIAN PATIENTS
Journal of Hepatology. 2011;54:S443   Crossref logo
Link1 Link2

Altered Serum Adipocytokines Levels Do Affect Hepatic Steatosis and Fibrosis in Chronic Hepatitis B and Chronic Hepatitis C Indian Patients
Journal of Clinical and Experimental Hepatology. 2011;1(1):30   Crossref logo
Link1 Link2

Chronic urinary retention in men: How we define it, and how does it affect treatment outcome
BJU International. 2012;110(11):1590-1594   Crossref logo
Link1

Does the presence of hepatic steatosis influence the efficacy of antiviral treatment in patients with hepatitis C?
Nature Clinical Practice Gastroenterology & Hepatology. 2007;4(10):548-549   Crossref logo
Link1 Link2 Link3

Hepatic steatosis — a sign of severity in the evolution of HCV chronic hepatitis?
Journal of Hepatology. 2001;34:159   Crossref logo
Link1 Link2

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks
Liver International. 2009;29(2):237-241   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.